Clinical Trial Update: An Open-Label Study to Evaluate PF-07994525 in Participants With Advanced Cancers [Phase 1]

View source ↗

Summary

Pfizer reports an open-label Phase 1 trial of PF-07994525 for advanced cancers; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• PF-07994525 (PF-07994525)

Snippet

Sponsor: Pfizer | Conditions: Advanced Malignancies, Advanced Cancer | Phase 1 | Status: NOT_YET_RECRUITING